{
    "clinical_study": {
        "@rank": "104214", 
        "arm_group": [
            {
                "arm_group_label": "Oxytocin", 
                "arm_group_type": "Experimental", 
                "description": "Oxytocin intranasal spray, 6 intranasal sufflations which deliver a total of 24 international units of oxytocin"
            }, 
            {
                "arm_group_label": "Placebo (for oxytocin)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Intranasal spray with all equivalent ingredients except oxytocin"
            }, 
            {
                "arm_group_label": "Lovingkindness Meditation", 
                "arm_group_type": "Experimental", 
                "description": "Lovingkindness guided meditation experienced in the laboratory and 6 additional LKM meditations taken home on the iPod."
            }, 
            {
                "arm_group_label": "Mindfulness Meditation", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Mindfulness guided meditation experienced in the laboratory and 6 additional Mindfulness meditations taken home on the iPod."
            }
        ], 
        "brief_summary": {
            "textblock": "The specific aim of this study is to test whether oxytocin (OT) boosts the positive emotion\n      yield of a new wellness behavior (Lovingkindness meditation or Mindfulness meditation) and\n      thereby increases nonconscious motives that shape daily behavioral decisions to repeat it,\n      which in turn foster positive emotions that further augment nonconscious motives in an\n      upward spiral dynamic.\n\n      The proposed research targets three hypotheses: (1) Oxytocin manipulation magnifies (i.e.,\n      moderates) the positive emotion yield of Lovingkindness meditation; (2) The positive emotion\n      yield of meditation, which varies by experimental condition, increases the nonconscious\n      incentive salience of Wellness Behavior-related cues; and (3) Behavioral decisions predict\n      positive emotions, sparking the relationships among OT manipulation, positive emotion yield,\n      and nonconscious incentive salience of Wellness Behavior-related cues."
        }, 
        "brief_title": "Study of Wellness Behaviors as a Function of Oxytocin vs Placebo", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sustained Positive Emotions", 
            "Sustained Positive Behavior Change"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  between the ages of 35 and 64 years old.\n\n          -  Fluent in written and spoken English\n\n          -  Willingness or interest in learning to meditate\n\n          -  Computer literate with access to internet (weekly)\n\n        Exclusion Criteria:\n\n          -  Women who are pregnant or breastfeeding\n\n          -  Individuals on antihypertensive medication\n\n          -  Individuals who have or have had a regular meditation practice\n\n          -  Individuals who can read Chinese logographs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "64 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01929161", 
            "org_study_id": "12-2371 IRB", 
            "secondary_id": "R01NR012899-03S2"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Oxytocin", 
                    "Lovingkindness Meditation", 
                    "Mindfulness Meditation"
                ], 
                "description": "24 International Units", 
                "intervention_name": "Oxytocin", 
                "intervention_type": "Drug", 
                "other_name": "Syntocinon"
            }, 
            {
                "arm_group_label": [
                    "Placebo (for oxytocin)", 
                    "Lovingkindness Meditation", 
                    "Mindfulness Meditation"
                ], 
                "description": "intranasal spray manufactured to mimic oxytocin nasal spray", 
                "intervention_name": "Placebo (for oxytocin)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Oxytocin", 
                    "Placebo (for oxytocin)", 
                    "Lovingkindness Meditation"
                ], 
                "intervention_name": "Lovingkindness Meditation", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Oxytocin", 
                    "Placebo (for oxytocin)", 
                    "Mindfulness Meditation"
                ], 
                "intervention_name": "Mindfulness Meditation", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "positive emotions", 
            "meditation", 
            "oxytocin"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "contact": {
                "email": "annfire@unc.edu", 
                "last_name": "Ann M Firestine, M.S.", 
                "phone": "919-942-4988"
            }, 
            "contact_backup": {
                "email": "pattyv@unc.edu", 
                "last_name": "Patty VanCappellen, Ph.D.", 
                "phone": "919-942-4988"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27519"
                }, 
                "name": "UNC PEP Lab"
            }, 
            "investigator": [
                {
                    "last_name": "Barbara L Fredrickson, Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Brian K Payne, Ph.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alison Steube, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sara Algoe, Ph.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Karen Grewen, Ph.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Affective and Genomic Mediators of Sustained Behavior Change: A Randomized, Dual-blind, Placebo-controlled Experimental Design That Will Examine Wellness Behavior as a Function of Oxytocin vs. Placebo.", 
        "overall_contact": {
            "email": "annfire@unc.edu", 
            "last_name": "Ann M Firestine, M.S.", 
            "phone": "919-942-4988"
        }, 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Barbara L Fredrickson, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Federal Government", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Modified Daily Emotions Scale (mDES) - This measure of explicit positive affect has been successfully used by the PI in multiple studies to detect changes in positive emotion. Previous work by the PI found that Cronbach's alpha coefficient for the mDES positive emotion composite variable was 0.93 in sample of mid-life community adults similar to those anticipated for this study.", 
                "measure": "Change in positive emotions (as measured by the Modified Daily Emotions Scale)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Weeks 1, 2, and 3"
            }, 
            {
                "description": "Affect Misattribution Procedure (AMP) - This measure of nonconscious incentive salience has acceptable internal consistency for an indirect measure of affect (.69 - .90) and has been found to predict judgments and behavioral outcomes above and beyond self-report measures.", 
                "measure": "Change in nonconscious incentive salience (as measured by the Affect Misattribution Procedure).", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Weeks 1, 2, and 3"
            }, 
            {
                "description": "Self-reported meditation time recorded daily and weekly. In addition, meditation track play times will be recorded from the iPod.", 
                "measure": "Changes in meditation time", 
                "safety_issue": "No", 
                "time_frame": "Weeks 1, 2, and 3"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01929161"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of North Carolina, Chapel Hill", 
            "investigator_full_name": "Barbara L. Fredrickson, PhD", 
            "investigator_title": "Kenan Distinguished Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "This measure of parasympathetic control over the heart has been positively associated with both emotional and social functioning. Previous work by the PI's team has found that baseline vagal tone  predicts increased positive response to lovingkindness meditation (LKM), and that LKM in turn increases vagal tone. Previous research by other labs has also found that OT administration increases vagal reactivity.", 
            "measure": "Cardiac Vagal Tone", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "source": "University of North Carolina, Chapel Hill", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Nursing Research (NINR)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of North Carolina, Chapel Hill", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}